Described herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medicine, such devices which includes a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with incredibly minimal permeability to oxygen and comp